Bill Search

HR 1051
  • Introduced
    Feb 06, 2025
  • Passed House
  • Passed Senate
  • Signed into Law
HR 1051
United States House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
Last Action See all actions
House • Feb 06, 2025: Referred to the House Committee on Energy and Commerce.

Summary/Bill Text

Comments on HR 1051

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Feb 06, 2025 | House
    • Introduced in House
    • Referred to the House Committee on Energy and Commerce.
Bill Texts
Looks like there aren't any bill texts available at this moment.
Documents
Looks like we don't have any documents available at this moment.
Sources